What DIC is and how it presents in neonates
Disseminated intravascular coagulation (DIC) is a systemic coagulation-pathway failure. In DIC, the body simultaneously over-activates its clotting system and exhausts its clotting factors, producing a paradoxical state in which both pathological clotting and pathological bleeding occur at the same time.
In neonates, DIC is triggered by a range of common stressors: severe infection (sepsis), asphyxia, extreme prematurity, metabolic acidosis, and multi-organ failure. All of these are conditions that critically ill preterm neonates frequently experience. The clinical presentation of DIC includes spontaneous haemorrhage from multiple sites (including puncture sites, the gut, the lungs, and intracranially), falling platelet counts, prolonged clotting times, and end-organ failure. These features overlap substantially with the haemorrhagic presentations described in the Letby case.
Coagulopathy of prematurity — the baseline disorder
Separate from DIC, coagulopathy of prematurity is an intrinsic baseline disorder of extremely preterm neonates. Preterm infants have developmentally immature coagulation systems. Their livers have not yet achieved adequate production of clotting factors, their platelet function is impaired, and their vitamin K stores are low. This means that, even without a superimposed trigger, extremely preterm neonates are at elevated risk of spontaneous bleeding that would not occur in a term infant.
The severity of coagulopathy correlates with gestational age: the more preterm the infant, the more pronounced the coagulation deficit. The infants at the centre of the Letby case ranged from approximately 23 to 34 weeks gestational age. Multiple were at the extreme end of viability, where coagulopathic bleeding is not a rare complication but an expected clinical risk that units manage routinely.
How DIC mimics deliberate-harm scenarios
The prosecution’s harm theory on several counts was that haemorrhage indicated physical injury or deliberate interference — specifically, that the site or extent of bleeding was inconsistent with natural causes. DIC and coagulopathy of prematurity produce haemorrhage that can be clinically indistinguishable from traumatic or deliberately induced haemorrhage, particularly in the absence of specific coagulation-screen testing.
Key features that DIC can produce and that might be mistakenly attributed to deliberate harm include: bleeding at intravenous access sites in excess of expected levels; spontaneous haemorrhagic collapse without a clear preceding event; pulmonary haemorrhage presenting as blood in the airway; and intraventricular or subdural haemorrhage without a history of head trauma. For each of these, the differential diagnosis must include DIC and coagulopathy before a deliberate-harm conclusion is reached.
The Mikael Norman thrombosis differential review and the Michael Hall pathology re-readings both identify DIC as an inadequately considered differential in several of the case post-mortem analyses. The absence of systematic coagulation screening at the time of each death means that, in many cases, DIC cannot be excluded from the clinical record.
Specific case relevance — the haemorrhage-feature counts
Of the 17 conviction counts, a significant subset involved haemorrhage as a prominent clinical feature. The prosecution characterised these as consistent with deliberate injury. The Panel’s case-by-case analysis identifies, for each of the haemorrhage-feature cases, whether DIC or coagulopathy of prematurity constitutes a plausible alternative explanation.
For Baby N, a coagulation-factor deficiency (haemophilia was subsequently raised as a possibility for the wider family) adds a specific individual-level coagulopathy differential that was not available to the trial jury. See Baby N — haemophilia differential for the detailed analysis. For Baby E, the haemorrhagic presentation was treated at trial as a distinctive harm indicator; see Baby E deep-dive for the Panel’s alternative assessment.
What the Panel report says
The Panel report addresses DIC as a differential across multiple case sections. Its consistent finding is that DIC or coagulopathy of prematurity were either affirmatively supported by the clinical record or could not be excluded from it, and that in either case the haemorrhagic presentation did not require a deliberate cause. The Panel notes that several post-mortem examinations did not include the specialised staining or clotting-factor assays that would have been necessary to confirm or exclude DIC, leaving the differential open.
The Panel also observes that the clinical management of several infants included interventions (aggressive resuscitation, repeated vascular access, vasopressor therapy) that are independently associated with iatrogenic haemorrhage and coagulation disruption. Resuscitation-associated liver injury, in particular, can produce haemorrhagic findings post-mortem that are structurally similar to those attributed to deliberate harm. See our post-mortem evidence page for the methodological context on post-mortem haemorrhage interpretation.